This title appears in the Scientific Report :
2008
Boron neutron capture therapy for glioblastoma: is it worth pursuing?
Boron neutron capture therapy for glioblastoma: is it worth pursuing?
Presently glioblastomas are incurable brain tumors. The prospect of treating this deadly disease has been the major justification for the current programs of boron neutron capture therapy (BNCT) throughout the world. However, based on pharmacological and cell biological considerations, it is improba...
Saved in:
Personal Name(s): | Linz, U. |
---|---|
Contributing Institute: |
Institut für Neurowissenschaften und Biophysik - Medizin; INB-3 |
Published in: | Technology in cancer research & treatment, 7 (2008) S. 83 - 88 |
Imprint: |
Schenectady, NY
Adenine Press
2008
|
Physical Description: |
83 - 88 |
Document Type: |
Journal Article |
Research Program: |
Funktion und Dysfunktion des Nervensystems |
Series Title: |
Technology in Cancer Research and Treatment
7 |
Subject (ZB): | |
Publikationsportal JuSER |
Presently glioblastomas are incurable brain tumors. The prospect of treating this deadly disease has been the major justification for the current programs of boron neutron capture therapy (BNCT) throughout the world. However, based on pharmacological and cell biological considerations, it is improbable that BNCT will ever be an effective therapy for this tumor. Indeed, a review of the published literature over the last 50 years fails to provide justification for developing BNCT past its present experimental stage. |